Logotype for Isofol Medical

Isofol Medical (ISOFOL) investor relations material

Isofol Medical Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Isofol Medical
Q2 2025 earnings summary26 Aug, 2025

Executive summary

  • Transitioned from planning to execution phase with a successful, fully guaranteed and oversubscribed rights issue, raising SEK 91 million gross and strengthening the financial position for continued clinical development.

  • Positive progress in the phase Ib/II clinical study for arfolitixorin, with the first cohort completed and the next dose level initiated.

  • Constructive pre-IND meeting with the FDA validated the clinical development plan for arfolitixorin in the U.S.

  • Japanese partner Solasia Pharma K.K. to finance and conduct phase II/III studies in Japan, expanding the clinical program's reach.

  • Participation in major scientific and business conventions, and establishment of a new advisory board.

Financial highlights

  • No revenue reported; net loss for Q2 was SEK -14.7 million, compared to SEK -11 million in Q2 last year; H1 2025 net loss was SEK -28.3 million, up from SEK -19.5 million year-over-year.

  • Cash and cash equivalents at June 30, 2025, were SEK 65.7 million, down from SEK 119.2 million a year earlier, prior to the rights issue completed in July.

  • Cash flow for the quarter was SEK -17 million, compared to SEK -9 million the previous year.

  • Operating costs increased due to higher personnel and external costs related to clinical studies.

  • No loans or material investments; R&D costs expensed as incurred.

Outlook and guidance

  • Strengthened cash position post-rights issue provides funding for at least the next 12 months.

  • Ongoing phase Ib/II study to continue with escalating doses and potential expansion to Japan in 2026.

  • Clinical trial is progressing as planned, with updates to be provided as cohorts advance.

  • Further updates on clinical progress and business development expected throughout the year.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Isofol Medical earnings date

Logotype for Isofol Medical
Q3 202512 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Isofol Medical earnings date

Logotype for Isofol Medical
Q3 202512 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Isofol Medical is a biopharmaceutical company developing oncology treatments. It focuses on improving existing chemotherapy-based therapies with novel formulations to enhance effectiveness and reduce side effects. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq First North Growth Market.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage